Deferiprone is an iron chelator medication used to treat thalassemia major. Suppliers of deferiprone market it in the form of 500mg and 1000mg oral tablets.
The developer and earliest manufacturer of deferiprone is Apotex Pharmaceuticals, which first introduced the drug into the market in 1994. It is currently approved in over 60 countries worldwide, including but not limited to China, Australia, the U.S., and across Europe. Apotex remains the largest manufacturer and supplier of deferiprone medications globally.
Retail prices per 100 (500mg) tablets of deferiprone are typically around 300 EUR.
Popular Searches
Amoxicillin
manufacturers
Atorvastatin
manufacturers
Benzocaine
manufacturers
Calcium carbonate
manufacturers
Cloperastine fendizoate
manufacturers
Gabapentin
manufacturers
Hyaluronic acid
manufacturers
Ibuprofen
manufacturers
Ivermectin
manufacturers
Levothyroxine
manufacturers
Lisinopril
manufacturers
Losartan
manufacturers
Magnesium
manufacturers
Melatonin
manufacturers
Metformin
manufacturers
Methotrexate
manufacturers
Metoprolol
manufacturers
Omeprazole
manufacturers
Paracetamol
manufacturers
Prednisone
manufacturers
Pregabalin
manufacturers
Semaglutide
manufacturers
Testosterone enanthate
manufacturers
Vitamin B12
manufacturers